Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Advanced Course on EGFR in Lung Cancer 2024: Hong Kong SAR

26 - 27 Jan 2024

Hong Kong SAR, China


Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning Objectives
  • To understand the role of molecular diagnostic test on tissue and plasma samples for diagnosis, monitoring and TKI resistance in management of EGFR M+ lung cancer
  • To comprehend management of early stage and local advanced EGFR M+ lung cancer
  • To gain updated information on optimal first line management and treatment of TKI resistance
  • To interrogate the potential use of immunotherapy for patients with EGFR M+ lung cancer

This event has been supported by an unrestricted educational grant from Janssen.

Filter by:

There are 14 resources available

Welcome and Introduction

Presenter: Tony S. K. Mok, HKSAR CN and Solange Peters, CH

Session: Welcome and introduction




This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.